tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ARCT Stock Latest News

Arcturus Therapeutics initiates ARCT-2304 study
The FlyArcturus Therapeutics initiates ARCT-2304 study
8d ago
ARCT
Arcturus initiates dosing in Phase 2 studies for CF and OTC deficiency
PremiumThe Fly
Arcturus initiates dosing in Phase 2 studies for CF and OTC deficiency
12d ago
ARCT
Arcturus Therapeutics receives FDA clearance to begin H5N1 vaccine trial
PremiumThe Fly
Arcturus Therapeutics receives FDA clearance to begin H5N1 vaccine trial
2M ago
ARCT
Arcturus Therapeutics (ARCT): Impressive Pipeline and Potentially Promising Future
PremiumMarket News
Arcturus Therapeutics (ARCT): Impressive Pipeline and Potentially Promising Future
2M ago
ARCT
Arcturus Therapeutics Reports Q3 2024 Financial Results and Milestones
PremiumCompany Announcements
Arcturus Therapeutics Reports Q3 2024 Financial Results and Milestones
2M ago
ARCT
Arcturus Therapeutics reports Q3 EPS (26c), consensus ($1.22)
PremiumThe FlyArcturus Therapeutics reports Q3 EPS (26c), consensus ($1.22)
2M ago
ARCT
Arcturus Therapeutics (ARCT) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Arcturus Therapeutics (ARCT) Q3 Earnings Cheat Sheet
2M ago
ARCT
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ARCT
BNTX
CSL, Arcturus Therapeutics announce Japan MHLW approval for Kostaive
PremiumThe Fly
CSL, Arcturus Therapeutics announce Japan MHLW approval for Kostaive
4M ago
ARCT
Arcturus Therapeutics receives clearance of IND application for ARCT-032
PremiumThe Fly
Arcturus Therapeutics receives clearance of IND application for ARCT-032
5M ago
ARCT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ARCT
ELAB
Arcturus Therapeutics Releases Updated Corporate Presentation
PremiumCompany Announcements
Arcturus Therapeutics Releases Updated Corporate Presentation
5M ago
8K
ARCT
Arcturus Therapeutics initiated with an Outperform at Leerink
PremiumThe FlyArcturus Therapeutics initiated with an Outperform at Leerink
5M ago
ARCT
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ARCT
ATNM
Arcturus Therapeutics price target raised to $63 from $60 at H.C. Wainwright
Premium
The Fly
Arcturus Therapeutics price target raised to $63 from $60 at H.C. Wainwright
5M ago
ARCT
Arcturus Therapeutics price target lowered to $72 from $86 at Canaccord
PremiumThe Fly
Arcturus Therapeutics price target lowered to $72 from $86 at Canaccord
6M ago
ARCT
Arcturus Therapeutics reports Q2 EPS (64c), consensus ($1.60)
PremiumThe Fly
Arcturus Therapeutics reports Q2 EPS (64c), consensus ($1.60)
6M ago
ARCT
ARCT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ARCT Upcoming Earnings Report: What to Expect?
6M ago
ARCT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
EBS
ARCT
3 Best Stocks to Buy Now, 7/3/2024, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 7/3/2024, According to Top Analysts
7M ago
ACM
APLD
Arcturus Therapeutics updates on OTC deficiency in CF programs
Premium
The Fly
Arcturus Therapeutics updates on OTC deficiency in CF programs
7M ago
ARCT
Arcturus Therapeutics Enhances Board with Industry Expert Dr. Slaoui
Premium
Company Announcements
Arcturus Therapeutics Enhances Board with Industry Expert Dr. Slaoui
7M ago
8K
ARCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >